| Yu Peng,Jiang-kui Liu,Qiang Lin. Clinical progression of lobaplatin in combination chemotherapy for patients with recurrence or metastatic cancer. Oncol Transl Med, 2014, 13: 386-391. |
| 洛铂联合方案在化疗后进展的晚期癌症中临床研究进展 |
| Clinical progression of lobaplatin in combination chemotherapy for patients with recurrence or metastatic cancer |
| Received:July 03, 2014 Revised:July 25, 2014 |
| DOI：10.1007/s10330-014-1350-z |
| 中文关键词: Lobaplatin；Chemotherapy；Recurrence；Metastasis；Combination chemotherapy |
| 英文关键词: lobaplatin; chemotherapy; recurrence; metastasis; combination chemotherapy |
| 基金项目: |
| Author Name | Affiliation | E-mail | | Yu Peng | Hebei North University,South Diamond Road,Gaoxin District | billhappy001@163.com | | Jiang-kui Liu | Department of Gastroenterology,Hebei Medical University Affiliated North China Petroleum Bureau General Hospital | | | Qiang Lin* | Department of Oncology,Hebei Medical University Affiliated North China Petroleum Bureau General Hospital | billhappy001@163.com |
|
| Hits: 9017 |
| Download times: 10483 |
| 中文摘要: |
| 以铂类为基础的化疗方案成为多种癌症治疗的重要手段。但许多患者在接受首次化疗后复发或转移，需要继续治疗。洛铂（lobaplatin, LBP）是第3代新的铂类抗肿瘤药物，本文就近年来以洛铂为基础的联合化疗方案在化疗后复发或转移患者治疗中的临床研究进展作一综述。 |
| 英文摘要: |
| The platinum-based combination chemotherapy has become one of the major modalities in anti-cancer treatment. After the first-line chemotherapy, many patients need further chemotherapy because of recurrence or metastasis. Lobaplatin (LBP) is one of the third generation platinum drugs,and this article briefly reviews the clinical progression of lobaplatin in combination chemotherapy for patients with recurrence or metastatic cancer. |
|
View Full Text
Download reader HTML全文 |
| Close |